A detailed history of Pro Share Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 291,410 shares of VRTX stock, worth $119 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
291,410
Previous 269,741 8.03%
Holding current value
$119 Million
Previous $126 Million 7.19%
% of portfolio
0.34%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $9.97 Million - $11 Million
21,669 Added 8.03%
291,410 $136 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $12 Million - $14.8 Million
-30,529 Reduced 10.17%
269,741 $126 Million
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $19.9 Million - $21.7 Million
48,699 Added 19.36%
300,270 $126 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $15.5 Million - $18.6 Million
-45,253 Reduced 15.25%
251,571 $102 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $11.9 Million - $12.8 Million
35,214 Added 13.46%
296,824 $103 Million
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $5.81 Million - $6.51 Million
-18,485 Reduced 6.6%
261,610 $92.1 Million
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $7.03 Million - $8.02 Million
24,813 Added 9.72%
280,095 $88.2 Million
Q4 2022

Feb 02, 2023

SELL
$285.76 - $321.48 $7.55 Million - $8.5 Million
-26,430 Reduced 9.38%
255,282 $73.7 Million
Q3 2022

Nov 04, 2022

SELL
$273.83 - $305.53 $13.3 Million - $14.9 Million
-48,614 Reduced 14.72%
281,712 $81.6 Million
Q2 2022

Aug 01, 2022

SELL
$234.96 - $292.55 $37.3 Million - $46.4 Million
-158,650 Reduced 32.45%
330,326 $93.1 Million
Q1 2022

May 10, 2022

SELL
$221.42 - $260.97 $6.25 Million - $7.36 Million
-28,213 Reduced 5.46%
488,976 $128 Million
Q4 2021

Feb 08, 2022

BUY
$177.01 - $223.45 $25.5 Million - $32.2 Million
144,037 Added 38.6%
517,189 $114 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $6.08 Million - $6.8 Million
33,518 Added 9.87%
373,152 $67.7 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $950,386 - $1.12 Million
-5,069 Reduced 1.47%
339,634 $68.5 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $9.31 Million - $10.9 Million
44,967 Added 15.0%
344,703 $74.1 Million
Q4 2020

Feb 09, 2021

BUY
$207.01 - $276.09 $7.67 Million - $10.2 Million
37,064 Added 14.11%
299,736 $70.8 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $8.91 Million - $10.6 Million
34,849 Added 15.3%
262,672 $71.5 Million
Q2 2020

Aug 03, 2020

BUY
$225.48 - $295.8 $6.16 Million - $8.08 Million
27,309 Added 13.62%
227,823 $66.1 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $17.1 Million - $21.2 Million
-85,641 Reduced 29.93%
200,514 $47.7 Million
Q4 2019

Feb 12, 2020

BUY
$166.71 - $223.91 $2.26 Million - $3.03 Million
13,551 Added 4.97%
286,155 $62.7 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $771,639 - $868,471
4,642 Added 1.73%
272,604 $46.2 Million
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $4.72 Million - $5.45 Million
-28,653 Reduced 9.66%
267,962 $49.1 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $4.46 Million - $5.3 Million
27,238 Added 10.11%
296,615 $54.6 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $4.01 Million - $5.07 Million
26,403 Added 10.87%
269,377 $44.6 Million
Q3 2018

Nov 14, 2018

SELL
$167.73 - $192.74 $4.22 Million - $4.85 Million
-25,163 Reduced 9.38%
242,974 $46.8 Million
Q2 2018

Aug 13, 2018

SELL
$145.72 - $169.96 $6.93 Million - $8.08 Million
-47,540 Reduced 15.06%
268,137 $45.6 Million
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $5.74 Million - $6.7 Million
37,852 Added 13.62%
315,677 $51.4 Million
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $8.31 Million - $9.41 Million
60,520 Added 27.85%
277,825 $41.6 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $2.26 Million - $2.47 Million
15,247 Added 7.55%
217,305 $33 Million
Q2 2017

Aug 11, 2017

BUY
N/A
202,058
202,058 $26 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.